Pulling SEC filings + quote and writing the call…

ESS Tech, Inc.
Next earnings Aug 12, 2026 (after close) · consensus $-0.44 EPS, $101K rev
Last earnings +5.1% on 2026-06-23
Sub-$1 pre-revenue-scale flow-battery story burning $50M/yr on $14.5M cash — dilution or going concern before the tech thesis pays off.
Revenue $1.58M · FY2025
ESS is a long-duration iron-flow battery developer that, after nearly 15 years, still has essentially no commercial revenue: FY2025 sales were just $1.58M, down 74.9% YoY, and the five-year record ($0 → $894K → $7.54M → $6.29M → $1.58M) shows revenue going backwards, not scaling. Worse, the company loses money on every dollar it sells — gross profit was -$27.7M on that $1.58M of revenue (a -1,748% gross margin), so cost of goods alone dwarfs sales before a single dollar of R&D or SG&A. Net loss was -$63.4M and operating cash flow was -$50.3M. The MD&A's entire value case is prospective — 'attractive margin unit economics if we are able to continue to reduce production costs and scale' and 'we believe our unique technology provides... favorable margins... in the future' — i.e., the economics that would justify owning this do not exist today and depend on a manufacturing ramp that has not materialized.
The balance sheet makes this urgent, not academic. Cash is only $14.5M against a $50.3M annual operating burn — well under four months of runway at the current pace. Stockholders' equity has collapsed 70.2% to $8.62M, liabilities are 4.94x equity, and the accumulated deficit is -$846M. Management has already been forced into heavy dilution: shares outstanding rose 124.5% YoY, and with FY2025 diluted EPS at -$4.34 the reported ~27.2M share count reflects a reverse split layered on top of that dilution — existing holders are being ground down on both axes. A near-term capital raise (further dilution) or a going-concern outcome is the base case, and the entire $23.5M market cap can be wiped by financing terms regardless of the technology.
Is GWH a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $894K | $7.54M | $6.29M | $1.58M |
| Gross profit | — | $894K | -$13.0M | -$45.4M | -$27.7M |
| Operating income | -$60.6M | -$105M | -$85.9M | -$89.8M | -$57.4M |
| Net income | -$477M | -$78.0M | -$77.6M | -$86.2M | -$63.4M |
| Diluted EPS | -$5.73 | -$0.51 | -$7.27 | -$7.32 | -$4.34 |
| Net margin | — | -8721.4% | -1028.9% | -1369.7% | -4007.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 3.01: received NYSE continued-listing deficiency/delisting notice
Results + Reg FD + other material event disclosed in a business update
Item 5.02: executive/board leadership change announced
Item 3.01: listing-standard deficiency notice; Reg FD disclosure
Item 5.07: annual meeting voting results reported
Q1 FY26: continued heavy losses and cash burn on weak revenue
Q1 FY26: continued heavy losses and cash burn on weak revenue
Annual meeting proxy: director, pay and auditor votes solicited
FY25 revenue -75% to $1.6M; $63M loss, equity down 70%, going-concern risk
Sources: SEC EDGAR (CIK 0001819438, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 7/4/2026, 9:27:51 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 5:27 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 4 sales
| 2026-06-04 | Buckley Drew P CEO | Buy | 25.0K @ $1.03 | $25.7K |
| 2026-05-29 | WELLMAN ALEXI Director | Award | 13.5K | |
| 2026-05-29 | Quarls Harry Director | Award | 13.5K | |
| 2026-05-29 | Nijhawan Sandeep Director | Award | 13.5K | |
| 2026-05-29 | Hossfeld Rich Director | Award | 13.5K | |
| 2026-05-29 | Garabedian Raffi Director | Award | 13.5K | |
| 2026-05-22 | Suhadolnik Kate Eileen Chief Financial Officer | Sell | 1.92K @ $0.93 | $1.80K |
| 2026-05-22 | Goodman Kelly F. SEE REMARKS | Sell | 2.75K @ $0.93 | $2.57K |
| 2026-05-21 | Suhadolnik Kate Eileen Chief Financial Officer | Sell | 1.74K @ $0.92 | $1.59K |
| 2026-05-21 | Goodman Kelly F. SEE REMARKS | Sell | 2.48K @ $0.92 | $2.28K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median